NearWave

Seed / Series A

defense-other · Seed

Seed Signal Score

9/25

Team Strength

2/5

Validation Depth

2/5

Novelty

2/5

Market Timing

1/5

Capital Efficiency

2/5

nearwave.co

Description

Helping physicians select the right therapy for breast cancer patients

Validation Signals

yc batch

Score Rationale

NearWave appears to be a medical AI company focused on breast cancer therapy selection, not a defense technology company. There is a complete mismatch between the stated industry (defense-other) and the actual product description (oncology). With no named founders, no defense credentials visible, no government contracts, and no clear defense application, this company scores weakly across all dimensions and should likely be filtered out as off-mandate for a defense tech fund.

Back to all companies